Teladoc (TDOC) looks like a classic turnaround setup — high risk, but with meaningful upside if execution plays out. The stock is trading around $8 after a brutal drawdown, pricing in a lot of pessimism. But under new leadership, Teladoc is aggressively cutting costs, improving free cash flow, and refocusing on its Integrated Care segment while stabilizing the underperforming BetterHelp unit. Recent acquisitions (Catapult, UpLift) support this shift toward more integrated, network-based services.
Technically, the setup is compelling: Bollinger Bands are tightening and there’s a divergence forming — both early signals of a potential breakout or reversal. If the company can continue delivering on margin improvement and steadying revenue, the market may start to rerate the story. Execution is key, but at these levels, it could offer deep-value exposure to a recovering digital health player.
Technically, the setup is compelling: Bollinger Bands are tightening and there’s a divergence forming — both early signals of a potential breakout or reversal. If the company can continue delivering on margin improvement and steadying revenue, the market may start to rerate the story. Execution is key, but at these levels, it could offer deep-value exposure to a recovering digital health player.
Trade active
Entry 8:00Target 16:00
SL: 6
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.